Diabetic Macular Edema Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetic Macular Edema stocks.

Recent Signals

Date Stock Signal Type
2021-05-06 AMPE Fell Below 20 DMA Bearish
2021-05-06 AMPE 50 DMA Support Bullish
2021-05-06 AMPE NR7 Range Contraction
2021-05-06 AMPE Hammer Candlestick Bullish
2021-05-06 AMPE Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-05-06 EYPT Fell Below 50 DMA Bearish
2021-05-06 EYPT Fell Below 20 DMA Bearish
2021-05-06 EYPT Expansion Pivot Sell Setup Bearish Swing Setup
2021-05-06 GRAY Expansion Breakdown Bearish Swing Setup
2021-05-06 GRAY New 52 Week Low Weakness
2021-05-06 GRAY New 52 Week Closing Low Bearish
2021-05-06 GRAY Bollinger Band Squeeze Range Contraction
2021-05-06 GRAY Reversal New Lows Setup Bearish Swing Setup
2021-05-06 KALV Hammer Candlestick Bullish
2021-05-06 KALV 20 DMA Resistance Bearish
2021-05-06 KALV Lizard Bullish Bullish Day Trade Setup
2021-05-06 KALV Bollinger Band Squeeze Range Contraction
2021-05-06 OCUP Pocket Pivot Bullish Swing Setup
2021-05-06 OCUP 20 DMA Resistance Bearish
2021-05-06 OPT Narrow Range Bar Range Contraction
2021-05-06 RZLT NR7 Range Contraction
2021-05-06 RZLT Narrow Range Bar Range Contraction
2021-05-06 RZLT Calm After Storm Range Contraction

Recent News for Diabetic Macular Edema Stocks

Diabetic retinopathy, also known as diabetic eye disease, is a medical condition in which damage occurs to the retina due to diabetes mellitus. It is a leading cause of blindness.Diabetic retinopathy affects up to 80 percent of those who have had diabetes for 20 years or more. At least 90% of new cases could be reduced with proper treatment and monitoring of the eyes. The longer a person has diabetes, the higher his or her chances of developing diabetic retinopathy. Each year in the United States, diabetic retinopathy accounts for 12% of all new cases of blindness. It is also the leading cause of blindness in people aged 20 to 64.

More about Diabetic Macular Edema
Browse All Tags